LEADER 03880nam 2200961z- 450 001 9910637783103321 005 20231214133216.0 010 $a3-0365-5492-0 035 $a(CKB)5470000001631706 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/94533 035 $a(EXLCZ)995470000001631706 100 $a20202212d2022 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aChallenges and Advances in Tuberculosis and Mycobacterial Lung Diseases 210 $aBasel$cMDPI - Multidisciplinary Digital Publishing Institute$d2022 215 $a1 electronic resource (140 p.) 311 $a3-0365-5491-2 330 $aThe Special Issue of the journal Diagnostics entitled ?Challenges and Advances in Tuberculosis and Mycobacterial Lung Diseases? encompasses research articles, case presentations, and literature reviews concerning the epidemiology, medical surveillance, as well as diagnostic and therapeutic challenges in tuberculosis (TB) and in the infections caused by non-tuberculous mycobacteria (NTM ). The articles present the current status of knowledge concerning the use of molecular tests and genotyping of M. tuberculosis for the rapid identification of MDR and XDR clones, the advances in the identification of NTM and their differentiation to the species level, as well as clinical studies performed in TB and NTM risk groups. In addition, a summary of current recommendations concerning diagnosis and treatment of tuberculous pericarditis is presented. 606 $aPublic health & preventive medicine$2bicssc 610 $aGordonia bronchialis 610 $amicrobiological diagnostics 610 $arespiratory infection 610 $aMycobacterium tuberculosis 610 $adrug resistance 610 $aXDR-tuberculosis 610 $ahousehold TB transmission 610 $atuberculous pericarditis 610 $aextrapulmonary tuberculosis 610 $apericarditis 610 $aconstrictive pericarditis 610 $atuberculosis 610 $aabscess 610 $ascrofula 610 $ahead and neck 610 $aepiglottis 610 $alarynx 610 $aairway 610 $amycobacteria 610 $asurgical drainage 610 $aFluoroType MTBDR 610 $amolecular 610 $aisoniazid 610 $arifampin 610 $abacillus Calmette-Guerin 610 $abladder cancer immunotherapy 610 $aBCGosis 610 $aBCG pulmonary infection 610 $asevere respiratory insufficiency 610 $anontuberculous mycobacterium 610 $alung cancer 610 $asurgery 610 $anontuberculous mycobacteria 610 $acystic fibrosis 610 $achest computed tomography 610 $aBeijing-TB 610 $aBeijing-like genotype 610 $aMycobacterium chimaera 610 $anontuberculous mycobacterial disease 610 $asilicosis 610 $aextracorporeal membrane oxygenation 610 $aCOVID-19 pandemic 610 $aspoligotyping 610 $aPoland 610 $ahuman immunodeficiency virus 610 $aacquired immunodeficiency syndrome 610 $achest imaging 610 $arapidly growing mycobacteria 610 $aantimicrobial resistance 610 $abroth microdilution 610 $aminimal inhibitory concentration (MIC) 615 7$aPublic health & preventive medicine 700 $aSzturmowicz$b Monika$4edt$01285499 702 $aAugustynowicz-Kope?$b Ewa$4edt 702 $aSzturmowicz$b Monika$4oth 702 $aAugustynowicz-Kope?$b Ewa$4oth 906 $aBOOK 912 $a9910637783103321 996 $aChallenges and Advances in Tuberculosis and Mycobacterial Lung Diseases$93019610 997 $aUNINA